← Back to Clinical Trials
Recruiting NCT05562557

NCT05562557 A Regional Partnership to Improve Outcomes Through Fatherhood Engagement

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05562557
Status Recruiting
Phase
Sponsor Montefiore Medical Center
Condition Substance Use
Study Type INTERVENTIONAL
Enrollment 240 participants
Start Date 2023-05-09
Primary Completion 2027-09

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Motivational EnhancementHERO Dads Fatherhood ProgramContingency Management

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 240 participants in total. It began in 2023-05-09 with a primary completion date of 2027-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Montefiore will engage fathers in families at risk of substance misuse in the Bronx and neighboring communities. Families will be referred from Bronx and neighboring community-based child welfare systems, substance use disorder (SUD) treatment providers, and medical providers if identified at risk of substance use concerns and will be randomly assigned to receive services as usual as part of the comparison group, or to receive enhanced services as part of the program group. Enhanced services include: (1) Motivational Enhancement; (2) referral to Healthy, Empowered, Resilient, and Open (HERO) Dads fatherhood engagement program; (3) Contingency Management; and (4) Case Management.

Eligibility Criteria

Inclusion Criteria: * is a custodial or non-custodial father * speaks English or Spanish * has at least one child under the age of 18, * someone in the family is identified as at-risk for substance use through: self-report of illicit substance use in the family, the presence of an SUD diagnosis in the family, a clinician/provider identified substance use risk, or the presence of a substance-related indicated child welfare allegation in the family Exclusion Criteria: * The placement of all children in the family in foster care

Contact & Investigator

Central Contact

Anita Jose, PhD

✉ ajose@montefiore.org

📞 718-401-5060

Principal Investigator

Scott Wetzler, PhD

PRINCIPAL INVESTIGATOR

Montefiore Medical Center

Frequently Asked Questions

Who can join the NCT05562557 clinical trial?

This trial is open to male participants only, aged 18 Years or older, studying Substance Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05562557 currently recruiting?

Yes, NCT05562557 is actively recruiting participants. Contact the research team at ajose@montefiore.org for enrollment information.

Where is the NCT05562557 trial being conducted?

This trial is being conducted at The Bronx, United States.

Who is sponsoring the NCT05562557 clinical trial?

NCT05562557 is sponsored by Montefiore Medical Center. The principal investigator is Scott Wetzler, PhD at Montefiore Medical Center. The trial plans to enroll 240 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology